<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-04095R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0002608</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology/Immunity to Infections</subject><subject>Infectious Diseases/Protozoal Infections</subject><subject>Radiology and Medical Imaging/Magnetic Resonance Imaging</subject><subject>Radiology and Medical Imaging/Magnetic Resonance Imaging</subject></subj-group></article-categories><title-group><article-title>Both Functional LT&#x003b2; Receptor and TNF Receptor 2 Are Required for the Development of Experimental Cerebral Malaria</article-title><alt-title alt-title-type="running-head">LTbR in Cerebral Malaria</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Togbe</surname><given-names>Dieudonn&#x000e9;e</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Loureiro de Sousa</surname><given-names>Paulo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fauconnier</surname><given-names>Mathilde</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Boissay</surname><given-names>Victorine</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fick</surname><given-names>Lizette</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Scheu</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pfeffer</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Menard</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Grau</surname><given-names>Georges E.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Doan</surname><given-names>Bich-Thuy</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Beloeil</surname><given-names>Jean Claude</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Renia</surname><given-names>Laurent</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hansen</surname><given-names>Anna M.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ball</surname><given-names>Helen J.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hunt</surname><given-names>Nicholas H.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ryffel</surname><given-names>Bernhard</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Quesniaux</surname><given-names>Valerie F. J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>University of Orl&#x000e9;ans and CNRS, Molecular Immunology and Embryology UMR6218, Orleans, France</addr-line></aff><aff id="aff2"><label>2</label><addr-line>CNRS CBM (Centre de Biophysique Mol&#x000e9;culaire), Orleans, France</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa</addr-line></aff><aff id="aff4"><label>4</label><addr-line>University of Duesseldorf, Duesseldorf, Germany</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Pasteur Institute Paris, Paris, France</addr-line></aff><aff id="aff6"><label>6</label><addr-line>The University of Sydney, Department of Pathology, Camperdown, Australia</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Institut Cochin, Universit&#x000e9; Paris Descartes, CNRS (UMR 8104), Paris, France</addr-line></aff><aff id="aff8"><label>8</label><addr-line>Inserm, U567, Paris, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Doolan</surname><given-names>Denise L.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Queensland Institute of Medical Research, Australia</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>bryffel@cnrs-orleans.fr</email> (BR); <email>quesniaux@cnrs-orleans.fr</email> (VQ)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: RM LR JB BR VQ GG DT NH MF VB PL SS AH. Performed the experiments: BD DT MF VB PL LF AH HB. Analyzed the data: RM KP LR JB BR VQ BD GG DT NH MF VB PL LF SS AH HB. Contributed reagents/materials/analysis tools: RM KP LR JB BD NH LF SS HB. Wrote the paper: KP BR VQ GG.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>9</day><month>7</month><year>2008</year></pub-date><volume>3</volume><issue>7</issue><elocation-id>e2608</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2008</year></date><date date-type="accepted"><day>4</day><month>6</month><year>2008</year></date></history><copyright-statement>Togbe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><sec><title>Background</title><p>TNF-related lymphotoxin &#x003b1; (LT&#x003b1;) is essential for the development of <italic>Plasmodium berghei</italic> ANKA (PbA)-induced experimental cerebral malaria (ECM). The pathway involved has been attributed to TNFR2. Here we show a second arm of LT&#x003b1;-signaling essential for ECM development through LT&#x003b2;-R, receptor of LT&#x003b1;1&#x003b2;2 heterotrimer.</p></sec><sec><title>Methodology/Principal Findings</title><p>LT&#x003b2;R deficient mice did not develop the neurological signs seen in PbA induced ECM but died at three weeks with high parasitaemia and severe anemia like LT&#x003b1;&#x003b2; deficient mice. Resistance of LT&#x003b1;&#x003b2; or LT&#x003b2;R deficient mice correlated with unaltered cerebral microcirculation and absence of ischemia, as documented by magnetic resonance imaging and angiography, associated with lack of microvascular obstruction, while wild-type mice developed distinct microvascular pathology. Recruitment and activation of perforin<sup>&#x0002b;</sup> CD8<sup>&#x0002b;</sup> T cells, and their ICAM-1 expression were clearly attenuated in the brain of resistant mice. An essential contribution of LIGHT, another LT&#x003b2;R ligand, could be excluded, as LIGHT deficient mice rapidly succumbed to ECM.</p></sec><sec><title>Conclusions/Significance</title><p>LT&#x003b2;R expressed on radioresistant resident stromal, probably endothelial cells, rather than hematopoietic cells, are essential for the development of ECM, as assessed by hematopoietic reconstitution experiment. Therefore, the data suggest that both functional LT&#x003b2;R and TNFR2 signaling are required and non-redundant for the development of microvascular pathology resulting in fatal ECM.</p></sec></abstract><counts><page-count count="12"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Cerebral malaria is a frequent cause of death in children and young adults infected with Plasmodium falciparum <xref ref-type="bibr" rid="pone.0002608-Miller1">&#x0005b;1&#x0005d;</xref>, which is characterized by the sequestration of parasitized erythrocytes in cerebral blood vessels <xref ref-type="bibr" rid="pone.0002608-Idro1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Hunt1">&#x0005b;3&#x0005d;</xref>. TNF has been originally implicated in pathogenesis of the neurological complication <xref ref-type="bibr" rid="pone.0002608-Schofield1">&#x0005b;4&#x0005d;</xref>. In patients with cerebral malaria disease severity has been correlated with TNF serum levels <xref ref-type="bibr" rid="pone.0002608-Grau1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002608-Kwiatkowski1">&#x0005b;7&#x0005d;</xref>. In experimental murine malaria the administration of TNF neutralizing antibodies prevented experimental cerebral malaria (ECM) <xref ref-type="bibr" rid="pone.0002608-Grau2">&#x0005b;8&#x0005d;</xref>. Mice with a combined inactivation of TNF and LT&#x003b1; were to be resistant to ECM development <xref ref-type="bibr" rid="pone.0002608-Rudin1">&#x0005b;9&#x0005d;</xref>. Recent data suggest that LT&#x003b1; rather than TNF is responsible for the development of microvascular damage resulting in the neurological malaria complication <xref ref-type="bibr" rid="pone.0002608-Engwerda1">&#x0005b;10&#x0005d;</xref>.</p><p>Lymphotoxin alpha is a member of TNF superfamily and the closest TNF relative. It exists as a soluble homotrimer (LT&#x003b1;3) or forms membrane-bound heterotrimers with the membrane associated lymphotoxin beta (LT&#x003b2;) <xref ref-type="bibr" rid="pone.0002608-Gommerman1">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Fu1">&#x0005b;12&#x0005d;</xref>. Both homotrimeric TNF and LT&#x003b1;3 interact with two receptors, TNFR1 (CD120&#x003b1;) and TNFR2 (CD120&#x003b2;), whereas membrane bound LT&#x003b1;&#x003b2; heterotrimers function through the engagement of LT&#x003b2;R <xref ref-type="bibr" rid="pone.0002608-Ware1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Hehlgans1">&#x0005b;14&#x0005d;</xref>. LT&#x003b2;R binds not only LT&#x003b1;&#x003b2; heterotrimers but also LIGHT homotrimers, another TNF family member. Both LIGHT and LT&#x003b1;3 bind herpes virus entry mediator (HVEM), a fourth member of TNFR superfamily. The role of soluble LT&#x003b1;3, of LT&#x003b1;&#x003b2; and LIGHT in pathogenesis is not fully understood.</p><p>Mice with complete inactivation of TNF or TNFR1 gene are unable to mount a protective response against various pathogens <xref ref-type="bibr" rid="pone.0002608-Flynn1">&#x0005b;15&#x0005d;</xref>, but develop ECM, while TNFR2 deficient mice are resistant to ECM development <xref ref-type="bibr" rid="pone.0002608-Stoelcker1">&#x0005b;16&#x0005d;</xref>. In order to assess the role of membrane LT&#x003b1;&#x003b2; heterotrimer signaling we studied ECM development in LT&#x003b2;R deficient mice <xref ref-type="bibr" rid="pone.0002608-Futterer1">&#x0005b;17&#x0005d;</xref> and further extended the investigation to LIGHT, using LIGHT gene deficient mice <xref ref-type="bibr" rid="pone.0002608-Scheu1">&#x0005b;18&#x0005d;</xref>.</p><p>Here we report that absence LT&#x003b2;R prevented ECM development. Magnetic resonance imaging (MRI) and angiography (MRA) were used to verify the lack of ischemia and microvascular pathology in these mice. Therefore, the data suggest that both functional LT&#x003b2;R and TNFR2 axis are required for the development of microvascular pathology resulting in fatal ECM. The disruption of either axis prevents cerebral microvascular disease.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Disruption of LT&#x003b2;R signaling protects from fatal ECM development</title><p>LT&#x003b1; and TNFR2 signaling have been shown to be critical for Plasmodium berghei ANKA (PbA) induced ECM, as mice deficient for either LT&#x003b1; or TNFR2 are resistant to cerebral malaria, while TNFR1 is dispensable <xref ref-type="bibr" rid="pone.0002608-Engwerda1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Stoelcker1">&#x0005b;16&#x0005d;</xref>. Since LT&#x003b1; exists either as soluble homotrimer or heterotrimer in association with membrane bound LT&#x003b2;, we asked whether signaling of membrane LT&#x003b1;&#x003b2; through LT&#x003b2;R may be involved in ECM development.</p><p>We show here that LT&#x003b2;R deficient mice did not develop ECM and survived more than 20 days, while C57BL/6J wild type mice developed typical neurological signs of CM, including postural disorders, ataxia, impaired reflexes and loss of grip strength, progressive paralysis and coma, and succumbed within a week after infection with 5&#x02013;10&#x00025; of parasitized erythrocytes (<xref ref-type="fig" rid="pone-0002608-g001"><italic>Figure 1A</italic></xref>). In order to compare directly the requirement for different members of the TNF family, mice deficient for TNF, LT&#x003b1;, LT&#x003b2;, LIGHT, TNFR1 or TNFR2 were infected with blood stage PbA. LT&#x003b1; and TNFR2 deficient mice resisted to ECM development (<xref ref-type="fig" rid="pone-0002608-g001"><italic>Figure 1B, C</italic></xref>), with no neurological signs up to day 22&#x02013;25, at which time they succumbed of high parasitaemia and anemia (<xref ref-type="fig" rid="pone-0002608-g001"><italic>Figure 1D,E</italic></xref> and data not shown), consistent with published data <xref ref-type="bibr" rid="pone.0002608-Stoelcker1">&#x0005b;16&#x0005d;</xref>. In contrast, mice deficient for TNF, LIGHT or TNFR1 developed neurological signs and succumbed to ECM within 7&#x02013;10 days (<xref ref-type="fig" rid="pone-0002608-g001"><italic>Figure 1B, C</italic></xref>). LT&#x003b2; deficient mice were more susceptible than LT&#x003b1; deficient mice, although they did not show neurological signs in the first week of infection, and developed slightly higher parasitemia and anemia than wild-type mice (<xref ref-type="fig" rid="pone-0002608-g001"><italic>Figure 1D, E</italic></xref>). Therefore, our data demonstrate that LT&#x003b2;R signaling is necessary for ECM development.</p><fig id="pone-0002608-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002608.g001</object-id><label>Figure 1</label><caption><title>LT&#x003b2;R deficient mice do not develop PbA induced ECM.</title><p>C57BL/6 (WT) and mice deficient for LT&#x003b2;R (A), LT&#x003b1;, LT&#x003b2;, LIGHT or TNF (B) , TNFR1 or TNFR2 (C) were infected with 10<sup>6</sup><italic>P. berghei ANKA</italic> parasitized red blood cells and their survival monitored daily. At day 7, parasitemia (D) was significantly increased in LT&#x003b1;, LT&#x003b2; and LT&#x003b2;R-deficient mice (p&#x0003c;0.01) and red blood cell counts (E) were significantly reduced in LTbR-deficient mice (p&#x0003c;0.0001) and less so in LT&#x003b1; or LT&#x003b2; deficient mice (p&#x0003c;0.01). Results are from n&#x0200a;&#x0003d;&#x0200a;14&#x02013;33 mice per genotype pooled from five independent experiments. Logrank test analysis of the Kaplan-Meyer curves indicated p values &#x0003c;0.0001 for each genotype compared to WT, with the exception of LIGHT-deficient mice which was non significant (0.3) and TNF-deficient mice (&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0002608.g001"/></fig></sec><sec id="s2b"><title>Absence of ECM signs in LT&#x003b2;-R deficient mice correlates with MRI and MRA based morphological analysis</title><p>Magnetic resonance imaging (MRI) is a non-invasive tool to investigate neurological disease processes in humans. In the murine experimental cerebral malaria model using MRI allow a semi-quantitative analysis of brain swelling, microvascular pathology due to obstruction of small vessels with parasitized erythrocytes and leukocytes endothelial damage, edema and focal ischemia <xref ref-type="bibr" rid="pone.0002608-Engwerda1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Stoelcker1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Penet1">&#x0005b;19&#x0005d;</xref>. Mice deficient for LT&#x003b2;R, LT&#x003b1;&#x003b2;&#x02013;deficient mice used as ECM resistant controls, and wild-type C57BL/6 or TNF-deficient mice used as ECM sensitive controls, were examined by MRI at day 7, when wild-type mice are dying with acute ECM, while LT&#x003b2;R and LT&#x003b1;&#x003b2;&#x02013;deficient mice were all alive without neurological signs.</p><p>Typical MRI and MRA images of uninfected and infected mice are shown in <xref ref-type="fig" rid="pone-0002608-g002"><italic>Figure 2A and 2B</italic></xref>, respectively. While wild-type C57BL/6 and TNF-deficient mice presented signs of ischemic brain damage and vascular blood flow perturbations upon blood stage PbA infection, LT&#x003b1;&#x003b2; and LT&#x003b2;R deficient mice displayed a normal MRI. Overall, mice deficient for LTa&#x003b2; (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;6) or LT&#x003b2;R (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;7) showed unaltered MRI and MRA signals. By contrast, wild-type mice showed altered MRI, observable as a bilateral hyperintense signal at the corpus callosum and external capsule (<xref ref-type="fig" rid="pone-0002608-g002"><italic>Figure 2A</italic></xref>), and a remarkable vascular blood flow perturbations was detected in wild-type mice (<xref ref-type="fig" rid="pone-0002608-g002"><italic>Figure 2B</italic></xref>). In addition, brain swelling was observed in infected wild-type C57BL/6 mice during acute cerebral malaria. TNF deficient mice showed an intermediate phenotype with an altered MRI and MRA perturbation in infected mice analyzed. Non-infected wild-type or gene deficient mice presented normal MRI and MRA phenotype (<xref ref-type="fig" rid="pone-0002608-g002"><italic>Figure 2A, B</italic></xref>). MRA 3D reconstitutions available in supplementary data show the clear difference in brain blood flow between non infected wild-type mice (<xref ref-type="supplementary-material" rid="pone.0002608.s001"><italic>Video S1_B6_NI</italic></xref>), 7 day PbA infected wild-type (<xref ref-type="supplementary-material" rid="pone.0002608.s002"><italic>Video S2_B6_PbA</italic></xref>) and TNF-deficient mice (<xref ref-type="supplementary-material" rid="pone.0002608.s003"><italic>Video S3_TNF ko_PbA</italic></xref>) on the one hand, and mice deficient for LT&#x003b2;R (<xref ref-type="supplementary-material" rid="pone.0002608.s004"><italic>Video S4_LT&#x003b1;&#x003b2; ko_PbA</italic></xref>) or LT&#x003b1;&#x003b2; (<xref ref-type="supplementary-material" rid="pone.0002608.s005"><italic>Video S5_LT&#x003b2;R ko_PbA</italic></xref>), on the other hand.</p><fig id="pone-0002608-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002608.g002</object-id><label>Figure 2</label><caption><title>MRI analysis of PbA induced morphological changes.</title><p>A. MRI of uninfected and infected mice, 7 days post infection with 10<sup>6</sup><italic>P. berghei ANKA</italic> parasitized red blood cells: Distinct anomalies are visible in C57BL/6 (WT) and TNF mice, namely edema formation, apparent as a bilateral hyperintense signal as indicated by arrows in the right 2 sets of photographs at the corpus callosum (c.c.) and external capsule (e.c.), while LT&#x003b1;&#x003b2; and LT&#x003b2;R deficient mice do not show these alterations. LV and 3V indicate the lateral and third ventricles, respectively. Images correspond to the stereotaxic position Bregma &#x02212;2.92 and &#x02212;0.58 mm. B. Magnetic Resonance Angiography: when compared to uninfected mice (left panel) vascular blood flow perturbations (shown by arrows) are evident in WT and TNF-KO mice, 7 days post infection with 10<sup>6</sup><italic>P. berghei ANKA</italic> parasitized red blood cells, while LT&#x003b1;&#x003b2; and LT&#x003b2;R deficient mice seem unaffected (middle panel). Sagittal MR images obtained from the same infected mice (right panel) indicate the main MRI alterations: oedema formation and cerebellar damage (shown by arrows). Brain swelling has been observed only in C57BL/6 and TNF-KO mice. MRA 3D reconstructions are shown in supplementary data.</p></caption><graphic xlink:href="pone.0002608.g002"/></fig><p>Therefore, LT&#x003b1;&#x003b2;-LT&#x003b2;R signaling is necessary to develop ischemic brain damage and vascular blood flow perturbations.</p></sec><sec id="s2c"><title>LT&#x003b2;R deficient mice do not develop microvascular lesions</title><p>In order to validate functionally the data obtained by MRI, we investigated microvascular lesions in the brain. Microvessel obstruction and disruption, which leads to increased protein extravasation from the capillary bed, was quantified by Evans blue leakage into the tissue. PbA infected wild-type or TNF deficient mice showed a strong vascular leak of Evans blue, while mice deficient for LT&#x003b1;&#x003b2; or LT&#x003b2;R had no discoloration of the brain parenchyma (<xref ref-type="fig" rid="pone-0002608-g003"><italic>Figure 3A</italic></xref>), with limited Evans blue vascular leak (<xref ref-type="fig" rid="pone-0002608-g003"><italic>Figure 3B</italic></xref>), suggestive of an intact blood-brain barrier.</p><fig id="pone-0002608-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002608.g003</object-id><label>Figure 3</label><caption><title>LT&#x003b2;R deficient do not develop ECM-associated brain vascular leakage.</title><p>Vascular leak as assessed by the blue discoloration of the brain of wild-type control C57BL/6 (WT), TNF, LT&#x003b1; or LT&#x003b2;R deficient mice injected intravenously with 1&#x00025; Evans blue on day 7 with severe ECM (A). Mice were infected with 10<sup>6</sup><italic>P. berghei ANKA</italic> parasitized red blood cells as in <xref ref-type="fig" rid="pone-0002608-g001">Fig. 1</xref>. Quantitative assessment of brain capillary permeability using Evans blue extravasation in formamide was measured by Absorbance at 610 nm in brain extract (B). Microvascular damage with mononuclear cell adhesion and perivascular hemorrhage in the brain of WT and TNF deficient mice, but not LT&#x003b1;, nor LT&#x003b2;R deficient, micrograph 400&#x000d7;, H&#x00026;E stained brain sections (C). Semi-quantitative score of brain infiltration and hemorrhages (D). Microvascular damage of lung alveolar septae of B6 and TNF deficient mice, but not of LT&#x003b2;R deficient, micrograph 400&#x000d7;, H&#x00026;E stained brain sections (E). semi-quantitative score of lung capillary (F&#x02013;G). The data morphological data are from one representative out of 4&#x02013;5 mice per group, and calculated date represent the mean&#x000b1;SD of n&#x0200a;&#x0003d;&#x0200a;4 mice per group (n.s., not significant).</p></caption><graphic xlink:href="pone.0002608.g003"/></fig><p>Microscopically, the vascular leak is due to microvascular lesions in the brain with perivascular hemorrhage and intravascular accumulation of mononuclear cells and infected erythrocytes (<xref ref-type="fig" rid="pone-0002608-g003"><italic>Figure 3C</italic></xref>), which was completely absent in LT&#x003b1;&#x003b2; and LT&#x003b2;R deficient mice. The severity of microvascular obstruction and local hemorrhage in the brain were assessed semi-quantitatively, and clearly demonstrate significant differences. The information obtained by MRI was compared to that derived from the microscopic examination of the brain. There was a good agreement of the predicted brain pathology by MRI and microscopic investigation.</p><p>Since microvascular disease occurring in PbA infected mice presenting with CM is not limited to the brain, we also investigated the pulmonary microvascular beds. While the lungs of wild-type and TNF-deficient mice displayed congested septal capillaries, hemorrhages and interstitial edema, LT&#x003b1;&#x003b2; or LT&#x003b2;R deficient mice had no evidence of microvascular pathology, with less erythrocytes in the alveoli (<xref ref-type="fig" rid="pone-0002608-g003"><italic>Figure. 3E, G</italic></xref>). However, wild-type, TNF, LT&#x003b1;&#x003b2; and LT&#x003b2;R deficient mice had comparable thickening of alveolar septae (<xref ref-type="fig" rid="pone-0002608-g003"><italic>Figure 3F</italic></xref>).</p><p>Therefore, the data suggest that disruption of LT&#x003b1;&#x003b2; &#x02013; LT&#x003b2;R signaling prevents microvascular pathology induced by PbA blood stage infection.</p></sec><sec id="s2d"><title>Reduced sequestration of effector T lymphocytes in the brain of PbA infected LT&#x003b2;R deficient mice</title><p>Trafficking and recruitment of effector T lymphocytes into the brain are clearly necessary for the development of the pathology associated with ECM <xref ref-type="bibr" rid="pone.0002608-Belnoue1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Nitcheu1">&#x0005b;21&#x0005d;</xref>. We next characterized brain-sequestered leukocytes, in wild-type and TNF deficient mice with severe neurological symptoms after PbA infection and in LT&#x003b2;R or LT&#x003b2; deficient mice at the same day after infection. Similar numbers of CD4<sup>&#x0002b;</sup> T cells were recovered from uninfected and infected wild-type mice, as well as from PbA infected TNF or LT&#x003b2; deficient mice (<xref ref-type="fig" rid="pone-0002608-g004"><italic>Figure 4A, E</italic></xref>). Interestingly, the strong increase in brain CD8<sup>&#x0002b;</sup> T cells seen in wild type or TNF deficient mice that develop cerebral malaria was essentially absent in PbA-infected LT&#x003b2;R or LT&#x003b2; deficient mice (<xref ref-type="fig" rid="pone-0002608-g004"><italic>Figure 4A, F</italic></xref>). We then analysed the functional state and cytotoxic potential of brain-sequestered CD8<sup>&#x0002b;</sup> T cells from PbA-infected mice (<xref ref-type="fig" rid="pone-0002608-g004"><italic>Figure 4B, G</italic></xref>). Most brain CD8<sup>&#x0002b;</sup> T cells expressed perforin in PbA-infected wild-type or TNF deficient mice, but ECM resistant LT&#x003b2;R deficient mice sequestered far less perforin<sup>&#x0002b;</sup> CD8 T lymphocytes (<xref ref-type="fig" rid="pone-0002608-g004"><italic>Figure 4B, G</italic></xref>). Moreover, we show that LT&#x003b2;R or LT&#x003b2; deficient mice have lower numbers of ICAM/CD54<sup>&#x0002b;</sup> and CD69<sup>&#x0002b;</sup> CD8 T cells than wild type or TNF deficient mice upon PbA infection (<xref ref-type="fig" rid="pone-0002608-g004"><italic>Figure 4C,D, H, I</italic></xref>). LT&#x003b2; deficient mice were only partially protected and succumbed to lethal ECM a few days later than the wild-type mice.</p><fig id="pone-0002608-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002608.g004</object-id><label>Figure 4</label><caption><title>Reduced CD8<sup>&#x0002b;</sup>T lymphocytes infiltration in the brain of PbA-infected LT&#x003b2;R deficient mice.</title><p>Flow cytometric analyses of brain-sequestered leukocytes from uninfected wild-type mice (WT NI), PbA-infected wild-type mice (WT PbA) and TNF deficient mice with severe ECM, and infected, ECM resistant LT&#x003b2; and LT&#x003b2;R deficient mice tested on the same day. Mice were infected with 10<sup>6</sup><italic>P. berghei ANKA</italic> parasitized red blood cells as in <xref ref-type="fig" rid="pone-0002608-g001">Fig. 1</xref>. Representative dot blots of CD4 and CD8 staining (A) CD8 and perforin double staining (B). Activation markers CD54 (C) and CD69 (D) on CD8<sup>&#x0002b;</sup> cells are shown for non infected (thin line) and PbA infected (thick line) WT, TNF-, LT&#x003b2;R- and LT&#x003b2;&#x02013;deficient mice, as indicated. Bargraphs of CD4<sup>&#x0002b;</sup> (E), CD8<sup>&#x0002b;</sup> (F), CD8<sup>&#x0002b;</sup> Perforin<sup>&#x0002b;</sup> (G), CD8<sup>&#x0002b;</sup> CD54<sup>&#x0002b;</sup> (H), and CD8<sup>&#x0002b;</sup> CD69<sup>&#x0002b;</sup> (I) lymphocytes represent the mean&#x000b1;SD of n&#x0200a;&#x0003d;&#x0200a;3&#x02013;4 pools of 3&#x02013;4 mice per group, and are from one representative of two independent experiments (n.s., not significant).</p></caption><graphic xlink:href="pone.0002608.g004"/></fig><p>In conclusion, these data suggest a pathogenic role of activated effector CD8<sup>&#x0002b;</sup> T lymphocytes recruited in brain of wild-type and TNF deficient mice developing ECM, whereas the ECM resistance in LT&#x003b2;R deficient mice is associated with strongly reduced sequestration of CD8<sup>&#x0002b;</sup> T lymphocytes.</p></sec><sec id="s2e"><title>Parasitaemia is LT&#x003b1;&#x003b2;-LT&#x003b2;R signaling independent</title><p>We then asked whether parasitaemia and anemia are influenced in the absence of LT&#x003b2;R signaling. Parasitaemia was analyzed by flow cytometry using GFP transfected parasites <xref ref-type="bibr" rid="pone.0002608-Voza1">&#x0005b;22&#x0005d;</xref>. Parasitaemia is usually low (less than 10&#x00025;) at the time of ECM onset. Absence of LT&#x003b2;R had no effect on parasitaemia as compared to wild-type mice at day 7 (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5A</italic></xref>). However, mice deficient for either LT&#x003b1; or LT&#x003b2;R developed extremely high parasitaemia of about 70&#x00025; by day 20 (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5B</italic></xref>), consistent with published data in LT&#x003b1; deficient mice <xref ref-type="bibr" rid="pone.0002608-Engwerda1">&#x0005b;10&#x0005d;</xref>.</p><fig id="pone-0002608-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002608.g005</object-id><label>Figure 5</label><caption><title>Parasitaemia and hematological alterations LT&#x003b2;R <italic>deficient mice</italic>.</title><p>The percentage of parasitized erythrocytes in the peripheral blood was determined up to day 22 for ECM resistant mice (A) after infection with 10<sup>6</sup> red blood cells parasitized by EGFP expressing <italic>P. berghei ANKA</italic>, by flow cytometry analysis of GFP fluorescent erythrocytes. Total platelet, lymphocyte and erythrocyte counts and hematocrit were determined in the peripheral blood of non infected (N.I.) and 7 day infected C57BL/6 and LT&#x003b2;R deficient mice (B&#x02013;I). Anemia develops in LT&#x003b2;R deficient mice on day 18 after infection (I). The data represent the mean&#x000b1;SD of n&#x0200a;&#x0003d;&#x0200a;5&#x02013;12 mice per group from two independent experiments (n.s.; not significant).</p></caption><graphic xlink:href="pone.0002608.g005"/></fig><p>The hematological investigations at 7 days after infection revealed distinct reductions of platelet counts in C57BL/6 mice as compared to non-infected mice (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5C</italic></xref>), as reported <xref ref-type="bibr" rid="pone.0002608-Grau3">&#x0005b;23&#x0005d;</xref>, and we show a similar thrombocytopenia in the ECM resistant LT&#x003b2;R deficient mice (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5D</italic></xref>). The latter finding suggests that thrombocytopenia in LT&#x003b2;R deficient mice is not an indicator of platelet sequestration in microvessels in this model.</p><p>The total white blood cell counts decreased after 7 days of PbA infection in wild type mice, and this was largely attributed to a decrease in lymphocytes (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5E</italic></xref>), while monocyte and neutrophil counts were essentially unaffected (data not shown). LT&#x003b2;R deficient mice also experienced a marked decrease in lymphocyte counts (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5F</italic></xref>).</p><p>Finally, no significant anemia developed in wild-type mice 7 days post-infection, the erythrocyte count was still in the normal range (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5G</italic></xref>) as well as the hematocrit (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5I</italic></xref>) and hemoglobin concentrations (data not shown). Erythrocyte counts and hematocrit were slightly decreased on day 7 in LT&#x003b2;R deficient mice (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5H, J</italic></xref>). The ECM resistant, LT&#x003b2;R deficient mice further developed dramatic anemia (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5H</italic></xref>), similar to LT&#x003b1; deficient mice (1.34&#x000b1;0.30&#x000d7;10<sup>6</sup> RBC/&#x000b5;L), and probably succumb of general hypoxia after 3 weeks.</p><p>In conclusion, the resistance to ECM development of LT&#x003b1; and LT&#x003b2;R deficient mice was not attributable to decreased parasitaemia or thrombocytopenia, and the ECM resistant mice developed very high parasitaemia and died of severe anemia within 3 weeks.</p></sec><sec id="s2f"><title>Absence of LT&#x003b2;R expression on stromal cells determines resistance to ECM</title><p>To assess the cellular source of LT&#x003b2;R that mediates resistance toward ECM development, we generated bone marrow chimeric mice. Wild-type C57BL/6 and LT&#x003b2;R deficient mice were lethally irradiated and engrafted with bone marrow from either C57BL/6 mice or LT&#x003b2;R deficient mice <xref ref-type="bibr" rid="pone.0002608-Muller1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Ryffel1">&#x0005b;25&#x0005d;</xref>. After infection with 10<sup>6</sup><italic>P. berghei ANKA</italic> parasitized erythrocytes, wild-type mice reconstituted with LT&#x003b2;R deficient bone marrow died as rapidly as wild-type mice reconstituted with wild-type bone marrow (<xref ref-type="fig" rid="pone-0002608-g006"><italic>Figure 6A</italic></xref>). In contrast, LT&#x003b2;R deficient mice reconstituted with wild-type bone marrow displayed protection to ECM comparable to LT&#x003b2;R deficient mice reconstituted with LT&#x003b2;R deficient bone marrow, and further developed severe fatal anaemia, but no cerebral syndrome. Erythrocyte counts and hematocrit were already decreased on day 7 in LT&#x003b2;R deficient mice reconstituted with either LT&#x003b2;R deficient or wild-type bone marrow (<xref ref-type="fig" rid="pone-0002608-g006"><italic>Figure 6B,C</italic></xref>), similar to non reconstituted LT&#x003b2;R deficient mice (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5H, J</italic></xref>). Platelet and lymphocyte count decrease seen 7 days after infection were largely dependent on the recipient mice (<xref ref-type="fig" rid="pone-0002608-g006"><italic>Figure 6D, E</italic></xref>), and were similar to non-reconstituted mice (<xref ref-type="fig" rid="pone-0002608-g005"><italic>Figure 5C&#x02013;F</italic></xref>). Since the resistance of LT&#x003b2;R deficient mice to ECM development was not corrected by wild-type bone marrow reconstitution, the data suggest that LT&#x003b2;R expression on radioresistant, stromal probably endothelial cells determines the sensitivity to ECM and bone marrow cells from LT&#x003b2;R can not transfer ECM resistance to sensitive wild-type mice.</p><fig id="pone-0002608-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002608.g006</object-id><label>Figure 6</label><caption><title>LT&#x003b2;R expressed on radioresistant stromal cells is critical for the development of ECM.</title><p>C56BL/6 (WT) or LT&#x003b2;R deficient (KO) recipient mice were lethally irradiated and reconstituted with bone marrow cells from WT or KO mice as indicated (donor BM&#x02192;recipient mice). The resulting WT&#x02192;WT, WT&#x02192;KO, KO&#x02192;WT and KO&#x02192;KO chimeric mice were infected with 10<sup>6</sup> parasitized erythrocytes and survival was recorded (A). Hematological parameters such as erythrocyte counts (B), hematocrit (C), lymphocyte (D) and platelet (E) counts were determined on day 7 in naive and <italic>P berghei Anka</italic> (PbA) infected mice. The data represent the mean&#x000b1;SD of n&#x0200a;&#x0003d;&#x0200a;5 mice per group (n.s., not significant).</p></caption><graphic xlink:href="pone.0002608.g006"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>The present data demonstrate that interruption of LT&#x003b2;R signaling abrogates the microvascular disease leading to fatal ECM, which sheds a new light on the pathogenesis of cerebral malaria. Indeed, since LT&#x003b1; and TNFR2 signaling are also required for ECM development, we propose that both functional TNFR2 and LT&#x003b2;R axes are required for the development of microvascular pathology resulting in fatal ECM. The disruption of either axis prevents cerebral microvascular alterations, indicating that the two signaling pathways are non-redundant.</p><p>Signaling through TNF receptors activate the classic NF-&#x003ba;B/RelA pathway mediated by the inhibitors I&#x003ba;B-&#x003b1;, -&#x003b2; and -&#x003b5;, leading to the expression of a large number of genes involved in inflammatory responses, cell adhesion or cell proliferation. In addition to the classic NF-&#x003ba;B/RelA pathway, LT&#x003b2;R signaling activates NF-&#x003ba;B through an alternative, non-canonical NIK-IKK1-dependent route that results in the activation of RelB/NF-&#x003ba;B2. The alternative pathway NF-&#x003ba;B is activated by a limited set of receptors including LT&#x003b2;R, CD27, CD40, BAFFR, RANK, but not by TNF receptors. A recent study identified p100 as a fourth I&#x003ba;B protein that is required and sufficient for non-canonical NF-&#x003ba;B signaling downstream of NIK and IKK1, while it acts also as a signal transducer of NF-&#x003ba;B/RelA <xref ref-type="bibr" rid="pone.0002608-Basak1">&#x0005b;26&#x0005d;</xref>. P100 was proposed as an integrator, involved in a cross-talk between canonical and non-canonical NF-&#x003ba;B inducing signaling that result in qualitative changes in the expression of inflammatory genes <xref ref-type="bibr" rid="pone.0002608-Basak1">&#x0005b;26&#x0005d;</xref>. Examples of dual requirement for TNFR and LT&#x003b2;R stimulation were described for the in vitro generation of fibroblast reticular cells from lymph node tissue <xref ref-type="bibr" rid="pone.0002608-Katakai1">&#x0005b;27&#x0005d;</xref>.</p><p>Although LT&#x003b1; deficient mice are resistant to ECM, LT&#x003b2; deficient mice were slightly less protected and absence of LIGHT did not prevent ECM. A similar apparent discrepancy, with milder phenotype for either LT&#x003b2; or LIGHT deficient mice as compared to LT&#x003b1; or LT&#x003b2;R deficient mice, was reported previously for lymphoid organogenesis <xref ref-type="bibr" rid="pone.0002608-Scheu1">&#x0005b;18&#x0005d;</xref>. Evidence for a cooperative role for LIGHT and LT&#x003b2;, existence of a weak LT&#x003b1;3-LT&#x003b2;R interaction or of an additional ligand for LT&#x003b2;R were proposed <xref ref-type="bibr" rid="pone.0002608-Scheu1">&#x0005b;18&#x0005d;</xref>. Here, LIGHT, another LT&#x003b2;R ligand appears to be redundant in pathogenesis of ECM to blood stage PbA infection.</p><p>We investigated several pathophysiological aspects of CM in LT&#x003b2;R-deficient mice and show that the absence of clinical signs of ECM is associated with normal cerebral perfusion as assessed by MRI. The in vivo imaging data correlated with absence of microvascular disease with accumulation of mononuclear cells, vascular leak, hemorrhage and inflammation in the brain. Further, platelet adherence to cerebrovascular endothelium was absent in LT&#x003b2;R-deficient mice (data not shown), which is an important factor in ECM development as reported before <xref ref-type="bibr" rid="pone.0002608-vonZurMuhlen1">&#x0005b;28&#x0005d;</xref>. Further pulmonary microvascular damage with alveolitis, plasma and erythrocyte leak in the alveolar space seen in control mice was also reduced in LT&#x003b2;R-deficient mice. Therefore, PbA induced microvascular damage in both lungs and brain is LT&#x003b2;R signaling dependent.</p><p>A previous report demonstrated a sex dependence of LT&#x003b2;R deficient mice infected with <italic>Plasmodium chabaudi</italic><xref ref-type="bibr" rid="pone.0002608-Wunderlich1">&#x0005b;29&#x0005d;</xref>, therefore we investigated whether males and females LT&#x003b2;R deficient mice have a differential susceptibility to PbA infection. However, we did not find any difference in susceptibility of male and female LT&#x003b2;R deficient mice to PbA infection unlike that reported for <italic>P. chabaudi</italic> infection <xref ref-type="bibr" rid="pone.0002608-Wunderlich1">&#x0005b;29&#x0005d;</xref>.</p><p>Since members of the TNF family are involved in lymphoid organogenesis, we next questioned whether ECM resistance might be related to lymphoid organ structure and function. ECM resistant LT&#x003b1;, LT&#x003b1;&#x003b2; or LT&#x003b2;R deficient mice lack lymph node (LN) formation, while partially protected LT&#x003b2; deficient mice retain mesenteric LNs and in some cases cervical LNs, and intact lymphoid organs develop in the ECM sensitive LIGHT deficient mice <xref ref-type="bibr" rid="pone.0002608-Scheu1">&#x0005b;18&#x0005d;</xref>. Therefore, although absence of LT&#x003b2;R led to a severe defect in LN organogenesis, mice singly deficient for either LT&#x003b2; or LIGHT retained mesenteric LN, suggesting a redundancy or partial compensation of the two ligands. Bone marrow reconstitution is classically used to separate the effects on lymphoid organogenesis from the functional defects in adult mice. Wild-type bone marrow reconstitution in TNF/LT&#x003b1; deficient mice, that corrects immunodeficiency but not LN formation <xref ref-type="bibr" rid="pone.0002608-Muller1">&#x0005b;24&#x0005d;</xref>, could not restore their sensitivity to ECM <xref ref-type="bibr" rid="pone.0002608-Engwerda1">&#x0005b;10&#x0005d;</xref>. Although the potential contribution of radiation-resistant brain endothelial cells, microglial cells or astrocytes as sources of LT&#x003b1; was proposed, the involvement of immune defects such as LN formation cannot be ruled out. We thus investigated in more details the inflammatory and hematological responses to PbA infections.</p><p>LT&#x003b2;R deficient mice, similar to wild-type mice, showed thrombocytopenia and decreased lymphocyte counts at day 7 when mice show signs of incipient CM, together with a slight anemia and slight increase in parasitaemia, that further increased thereafter. Therefore, disruption of LT&#x003b2;R signaling while protecting from ECM development, had no strong effect on the typical hematological / inflammatory response to PbA infection in mice. Further, absence of LT&#x003b1; or LT&#x003b2;R did not interfere with the progression of blood stage infection, and LT&#x003b1; or LT&#x003b2;R deficient mice succumb within 3 weeks of severe parasitaemia and anaemia.</p><p>Recent investigations demonstrated a potential for innate immune mechanisms directed against <italic>Plasmodium</italic> parasites to contribute to pathology and protection from malaria <xref ref-type="bibr" rid="pone.0002608-Hall1">&#x0005b;30&#x0005d;</xref>. Several cell types such as DC, macrophages, &#x003b3;&#x003b4; T, NK and NKT cells contribute to the innate response <xref ref-type="bibr" rid="pone.0002608-Stevenson1">&#x0005b;31&#x0005d;</xref>. Among them, non lymphoid hematopoietic cells, but also follicular dendritic cells and stroma cells express LT&#x003b2;R. Both human and murine DC are activated by blood stage parasites in a TLR9 dependent manner <xref ref-type="bibr" rid="pone.0002608-Pichyangkul1">&#x0005b;32&#x0005d;</xref>, which is possibly mediated by hemozoin derived from infection with the human parasites <xref ref-type="bibr" rid="pone.0002608-Coban1">&#x0005b;33&#x0005d;</xref>. NK cell are an important source of IFN&#x003b3; and disruption of IFN&#x003b3; signaling or NK cell depletion leads to increased parasitaemia and higher mortality in mouse models of malaria <xref ref-type="bibr" rid="pone.0002608-Stevenson1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Amani1">&#x0005b;34&#x0005d;</xref>. We have recently shown that macrophage derived IL-18 is required for NK cell activation by <italic>P. falciparum</italic> infected erythrocytes resulting in IFN&#x003b3; production, which depends on IL18R/MyD88 signaling on both macrophages and NK cells <xref ref-type="bibr" rid="pone.0002608-Baratin1">&#x0005b;35&#x0005d;</xref>. However, TLR signaling of NK cells is dispensable for their activation <xref ref-type="bibr" rid="pone.0002608-Baratin1">&#x0005b;35&#x0005d;</xref>. We extensively investigated the role of TLR and their adaptor proteins, in the control of ECM, but found that TLR signaling does not contribute to the development of ECM induced by blood-stage PbA <xref ref-type="bibr" rid="pone.0002608-Togbe1">&#x0005b;36&#x0005d;</xref> while others suggested TLR9-MyD88 dependence of ECM development.</p><p>CD8<sup>&#x0002b;</sup> T cells were recently shown to be the primary effectors of CM in the <italic>Plasmodium berghei</italic> ANKA mouse model, although their precise mechanism of action remains unresolved <xref ref-type="bibr" rid="pone.0002608-Renia1">&#x0005b;37&#x0005d;</xref>. CD8<sup>&#x0002b;</sup> T cells may mediate circulatory shock, vascular permeability changes, and edema in the brain during PbA infection <xref ref-type="bibr" rid="pone.0002608-Chang1">&#x0005b;38&#x0005d;</xref>. We therefore investigated whether absence of LT&#x003b2;R affects T cell response to PbA induced ECM, and whether the effect is direct. We show a clear reduction in brain-infiltrating CD8<sup>&#x0002b;</sup> cells in ECM resistant LT&#x003b2;R mice. The low recruitment and activation of CD8<sup>&#x0002b;</sup> T cells in the brain of LT&#x003b2;R deficient mice may be linked to a defective production of CXCR3 ligands CXCL9, 10, 11, essential for T cell migration to inflamed tissues, that are reduced in the absence of LT&#x003b2;R <xref ref-type="bibr" rid="pone.0002608-Gommerman1">&#x0005b;11&#x0005d;</xref>. Absence of LT&#x003b2;R seemed to have little incidence on the effector properties of the sequestered CD8<sup>&#x0002b;</sup> T cell which expressed perforin, although the overall population of perforin<sup>&#x0002b;</sup> CD8 cells was clearly reduced in LT&#x003b2;R deficient mice, due to a sharp decrease in CD8&#x0002b; population recruited in the brain. ICAM<sup>&#x0002b;</sup> and CD69<sup>&#x0002b;</sup> CD8<sup>&#x0002b;</sup> T cells were also largely reduced in the brain of PbA infected LTbR deficient mice. LT&#x003b1;/&#x003b2; expressing CD8<sup>&#x0002b;</sup> T cells might participate directly in the microvascular pathology, through an interaction with LT&#x003b2;R expressed on endothelial cells, leading to cell activation, expression of adhesion molecules or cytokine secretion. The diminished recruitment and activation of CD8<sup>&#x0002b;</sup> T cells in the brain of LT&#x003b2;R deficient mice may therefore be responsible for protection from ECM development.</p><p>Bone marrow irradiation chimera experiments revealed that LT&#x003b2;R expression on radioresistant resident stromal cells is essential for the development of ECM. Reconstitution of LT&#x003b2;R deficient mice with wild-type bone marrow did not confer sensitivity to ECM. Therefore, the data suggest that LT&#x003b2;R expressed on endothelial cells might be critical, and their absence may prevent the recruitment of CD8 lymphocytes into the brain and microvascular pathology.</p><p>The clinical relevance of the findings in mice are under investigation for gene polymorphism of the TNF/LT&#x003b1; locus <xref ref-type="bibr" rid="pone.0002608-Flori1">&#x0005b;39&#x0005d;</xref>. Association between TNF/LT&#x003b1; polymorphism and increased risk of cerebral malaria has been reported <xref ref-type="bibr" rid="pone.0002608-McGuire1">&#x0005b;40&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002608-Gimenez1">&#x0005b;43&#x0005d;</xref>, however more investigations are necessary to fully decipher the molecular bases of the link between disease manifestation and TNF/LT&#x003b1; polymorphism.</p><p>In conclusion, the data suggest that both functional LT&#x003b2;R and TNFR2 signaling are required and non-redundant for the development of microvascular pathology resulting in fatal ECM. The disruption of either axis prevents cerebral microvascular disease.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Mice</title><p>Mice deficient for TNF <xref ref-type="bibr" rid="pone.0002608-Marino1">&#x0005b;44&#x0005d;</xref>, LT&#x003b1; <xref ref-type="bibr" rid="pone.0002608-DeTogni1">&#x0005b;45&#x0005d;</xref>, LT&#x003b2; <xref ref-type="bibr" rid="pone.0002608-Alimzhanov1">&#x0005b;46&#x0005d;</xref> and LT&#x003b1;&#x003b2; <xref ref-type="bibr" rid="pone.0002608-Kuprash1">&#x0005b;47&#x0005d;</xref>, TNFR1 <xref ref-type="bibr" rid="pone.0002608-Rothe1">&#x0005b;48&#x0005d;</xref>, TNFR2 <xref ref-type="bibr" rid="pone.0002608-Erickson1">&#x0005b;49&#x0005d;</xref>, LT&#x003b2;R <xref ref-type="bibr" rid="pone.0002608-Futterer1">&#x0005b;17&#x0005d;</xref> or LIGHT deficient mice <xref ref-type="bibr" rid="pone.0002608-Scheu1">&#x0005b;18&#x0005d;</xref> were bred in the animal facility of the Transgenose Institute (CNRS, Orleans). All mice were on C57BL/6J genetic background (back-crossed at least 10 times, beside TNFR2 deficient mice that were back-crossed 2 times) and wild-type control C57BL/6J (WT) mice were used. For experiments, adult (7&#x02013;10 weeks old) mice were kept in filtered-cages in P2 animal facility. All animal experiments complied with the French Government's ethical and animal experiments regulations.</p></sec><sec id="s4b"><title>Experimental malaria infection</title><p>A cloned line of <italic>Plasmodium berghei</italic> ANKA (PbA) stably transfected with GFP was obtained from Dr. A Waters <xref ref-type="bibr" rid="pone.0002608-FrankeFayard1">&#x0005b;50&#x0005d;</xref>. Mice were infected by intraperitoneal injection of 10<sup>6</sup> parasitized erythrocytes as described before <xref ref-type="bibr" rid="pone.0002608-Rudin1">&#x0005b;9&#x0005d;</xref>. Mice were observed daily for clinical neurological signs of ECM culminating in ataxia, paralysis and coma. Parasitaemia was analyzed by flow cytometry <xref ref-type="bibr" rid="pone.0002608-Voza1">&#x0005b;22&#x0005d;</xref> at various time point and hematological parameters were assessed as indicated. Before succumbing to neurological symptoms, mice were killed for histological analysis of the brain, lung and liver.</p></sec><sec id="s4c"><title>Parasitaemia</title><p>Parasitaemia was assessed in 2 &#x000b5;l of blood collected from the tail vein at different time points post-infection with EGFP-Plasmodium berghei ANKA. Blood was diluted in 2 ml of PBS containing 0.5&#x00025; BSA and fluorescent cells analyzed by FACScan flow cytometer LSR (Becton Dickinson, Grenoble, France) using CellQuest software (Becton Dickinson, Grenoble, France).</p></sec><sec id="s4d"><title>Hematology</title><p>Blood was drawn into tubes containing EDTA (Vacutainer; Becton, Grenoble, France) as indicated and hematological parameters determined using 5-part-differential hematology analyzer MS 9.5 (Melet Schloesing Laboratoires, France).</p></sec><sec id="s4e"><title>Histology</title><p>For histological analysis, the mice were perfused under anesthesia with saline and the brain, lung, and liver from <italic>P berghei</italic> ANKA infected mice were fixed in 4&#x00025; phosphate-buffered-saline formaldehyde for 72 h as described before <xref ref-type="bibr" rid="pone.0002608-Rudin1">&#x0005b;9&#x0005d;</xref>. Three &#x000b5;m sections were stained with haematoxylin and eosin. CNS microvascular obstruction, erythrocyte accumulation in alveoli, thickening of alveolar septae were quantified using a semi-quantitative score with increasing severity of changes (0&#x02013;5) by two independent observers including a trained pathologist (BR) as described <xref ref-type="bibr" rid="pone.0002608-Rudin1">&#x0005b;9&#x0005d;</xref>.</p></sec><sec id="s4f"><title>Bone marrow chimera</title><p>C57BL/6J (WT) mice and LT&#x003b2;R deficient mice received lethal body irradiation (8 Gy). Fresh, nucleated bone marrow cells (5&#x000d7;10<sup>6</sup> per mouse) were injected into the lateral tail vein of the recipient mice 24 hours after irradiation. The reconstituted mice were used at 2 months after bone marrow transplantation <xref ref-type="bibr" rid="pone.0002608-Muller1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002608-Ryffel1">&#x0005b;25&#x0005d;</xref>.</p></sec><sec id="s4g"><title>Assessment of vascular leak</title><p>Mice were injected intravenously (i.v) with 0.2 ml of 1&#x00025; Evans blue (Sigma-Aldrich) on day 7, shortly before the death of the wild type mice. One hour later, mice were sacrificed and the coloration of brain was assessed. Brain and lung extravasation in formamide (Sigma-Aldrich) was evaluated by absorbance at 610 nm of the tissue extracts as an indicator of increased capillary permeability <xref ref-type="bibr" rid="pone.0002608-Rudin1">&#x0005b;9&#x0005d;</xref>.</p></sec><sec id="s4h"><title>Brain imaging using magnetic resonance imaging (MRI)</title><p>MRI experiments were performed in a horizontal 9.4 T/20-ECM Bruker Biospec MR system (Bruker Biospin, Wissembourg, France) equipped with gradients capable of switching 950 mT/m in 50 &#x000b5;s. A 12 elements linear birdcage coil (Bruker Biospin) with inner diameter of 35 mm and length 60 mm has been used to achieve uniform excitation and reception.</p><p>A custom-built stereotaxic head holder was used to fix the animals into the birdcage coil (see below). The mice were anaesthetized with isoflurane (1.5&#x02013;2.5&#x00025;) in an O2/N2O 1&#x02236;1 mixture applied with a face mask allowing free breathing. Respiration was monitored using a balloon taped to the abdomen and connected to a pressure transducer (SA Instruments, Inc., Stony Brook, NY, USA). The mice body temperature was kept at 37&#x000b1;0.5 &#x000b0;C throughout the experiment, using warm water circulation</p><p>Preparatory anatomical saggital MR images were performed using a MSME (multi-slices, multi-echoes) sequence, with the following parameters: RARE factor&#x0200a;&#x0003d;&#x0200a;8, TR/TE<sub>eff.</sub>&#x0200a;&#x0003d;&#x0200a;4000/46 ms, FOV&#x0200a;&#x0003d;&#x0200a;20&#x000d7;20 mm<sup>2</sup>, matrix&#x0200a;&#x0003d;&#x0200a;128&#x000d7;128, 1 slice 1 mm thickness, number of averages (NA)&#x0200a;&#x0003d;&#x0200a;1, experimental time&#x0200a;&#x0003d;&#x0200a;1 min.</p><p>Brain lesions and global changes in tissue structure have been accessed by T<sub>2</sub> weighted (T2w) MR images using a MSME sequence, with the following parameters: RARE factor&#x0200a;&#x0003d;&#x0200a;8, TR/TE<sub>eff.</sub>&#x0200a;&#x0003d;&#x0200a;5000/46 ms, FOV&#x0200a;&#x0003d;&#x0200a;17&#x000d7;17 mm<sup>2</sup>, matrix&#x0200a;&#x0003d;&#x0200a;256&#x000d7;192 (zero-filled to 256&#x000d7;256), 37 axial slices 0.5 mm thickness, NA&#x0200a;&#x0003d;&#x0200a;8, experimental time&#x0200a;&#x0003d;&#x0200a;16 min.</p><p>Measurements of vascular cerebral blood flow was performed by MR angiography (MRA) using a Fast Low Angle Shot (FLASH) sequence, with the following parameters: FOV&#x0200a;&#x0003d;&#x0200a;14&#x000d7;14 mm<sup>2</sup>, matrix&#x0200a;&#x0003d;&#x0200a;128&#x000d7;128, TR/TE&#x0200a;&#x0003d;&#x0200a;30/5 ms, 51 axial slices 0.3 mm thickness, NA&#x0200a;&#x0003d;&#x0200a;4, experimental time&#x0200a;&#x0003d;&#x0200a;13 min. Angiograms were produced by generating maximum intensity projections (MIP) after interpolating raw data to obtain an isotropic resolution (109 &#x000b5;m)<sup>3</sup>. Image analysis and processing were performed with the public domain software Image J (NIH, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij</ext-link>).</p></sec><sec id="s4i"><title>Isolation of brain- sequestered leukocytes</title><p>Mice with neurological symptoms of ECM were anaesthetized (at day 7&#x02013;8) and perfused with 10 ml of PBS/EDTA 0.02&#x00025; intra-cardiac to remove circulating red blood cells and leukocytes from the brain as described.<xref ref-type="bibr" rid="pone.0002608-Belnoue1">&#x0005b;20&#x0005d;</xref> Brains were removed and homogenized gently (30 sec at 4000 rpm) using the sterile disposable homogenization system Dispomix (Medic Tools AG, 6300-Zug, Switzerland) in RPMI 1640 medium containing 2&#x00025; FCS. Tissue-cell homogenates were passed through a nylon cell strainer (100 &#x000b5;m; Becton Dickinson Grenoble, France) and centrifuged at 400 g for 10 minutes. The mononuclear cells were then separated over a 30&#x00025; Percoll gradient (Amersham Biosciences AB, Uppsala, Sweden). Residual red blood cells were lyzed by hypotonic shock in ammonium chloride- potassium lysis buffer.</p></sec><sec id="s4j"><title>Flow cytometry analysis (FACS)</title><p>Brain-sequestered cells were collected, washed and saturated with mouse serum prior to the staining with fluorescence labelled antibodies for 30 minutes. The cells were then phenotyped by flow cytometry. T cells were identified by their forward side scatter and with the use of the following antibodies: rat anti-mouse CD4 conjugated to fluorescein isothiocyante (FITC) (clone GK1.5; Pharmingen San Diego, CA), rat anti-mouse CD8&#x003b1; conjugated to allophycocyanin (APC) (clone 53-6.7, Pharmingen San Diego, CA), rat anti-mouse Perforin conjugated to phycoerytthrin (PE) (clone JAW246, eBioscience San Diego, CA), rat anti-mouse CD69 conjugated to phycoerytthrin (PE) (clone H1,F3, Becton-Dickinson, Grenoble France), rat anti-mouse CD54 conjugated to PE (clone 3E2, Becton-Dickinson, Grenoble France) and isotype-matched control antibodies (Becton-Dickinson, Grenoble France). For each sample, 10000 cells were scored. Data were analyzed using a LSR II-Flow cytometer and CellQuest software (Becton-Dickinson, Grenoble France).</p></sec><sec id="s4k"><title>Statistical analysis</title><p>Data are presented as mean values and standard deviation (SD) indicated by error bars, if not otherwise indicated. Statistical significance was determined with Graph Pad Prism software (version 4.0, San Diego,CA). Differences between multiple groups were analyzed for statistical significance by means of one way non-parametric ANOVA test followed by Dunn's multiple comparison test for some data or Logrank Test, for others we used Kruskal-Wallis test followed by Dunn's multiple comparison test. P values of &#x0003c;0.05 were considered statistically significant.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0002608.s001"><label>Video S1</label><caption><p>3D MRA Video 1 : Non-infected C57BL/6 wild-type mouse. Three-dimensional (3D) Magnetic Resonance Angiography (MRA) movies of non-infected wild-type C57BL/6, and wild-type or mice deficient for TNF, LT&#x003b1;LT&#x003b2;, or LT&#x003b2;R 7 days post infection with 10e6 P. berghei ANKA parasitized red blood cells. Video 1 : Non-infected C57BL/6 wild-type mouse. Compared to 2D views, 3D MRA allows a better observation of the vascular blood flow perturbations in wild-type and TNF-KO mice. Before 3D reconstruction, two dimensional angiograms (2D-MRA) were produced by Maximum Intensity Projections (MIP) as described in the <xref ref-type="sec" rid="s4">Methods</xref> section. Movies were created by rotating the 2D-MRA views at different angles (using steps of 20 degrees). Image analysis and processing (including 3D MRA movies) were performed with the public domain software ImageJ (NIH, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij</ext-link>).</p><p>(1.71 MB AVI)</p></caption><media xlink:href="pone.0002608.s001.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0002608.s002"><label>Video S2</label><caption><p>3D MRA Video 2 : PbA-infected C57BL/6 mouse. Three-dimensional (3D) Magnetic Resonance Angiography (MRA) movies of non-infected wild-type C57BL/6, and wild-type or mice deficient for TNF, LT&#x003b1; &#x002dc;LT&#x003b2;, or LT&#x003b2;R 7 days post infection with 10e6 P. berghei ANKA parasitized red blood cells. Video 2 : PbA-infected C57BL/6 mouse. Compared to 2D views, 3D MRA allows a better observation of the vascular blood flow perturbations in wild-type and TNF-KO mice. Before 3D reconstruction, two dimensional angiograms (2D-MRA) were produced by Maximum Intensity Projections (MIP) as described in the <xref ref-type="sec" rid="s4">Methods</xref> section. Movies were created by rotating the 2D-MRA views at different angles (using steps of 20 degrees). Image analysis and processing (including 3D MRA movies) were performed with the public domain software ImageJ (NIH, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij</ext-link>).</p><p>(1.92 MB AVI)</p></caption><media xlink:href="pone.0002608.s002.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0002608.s003"><label>Video S3</label><caption><p>3D MRA Video 3 : PbA-infected TNF ko mouse. Three-dimensional (3D) Magnetic Resonance Angiography (MRA) movies of non-infected wild-type C57BL/6, and wild-type or mice deficient for TNF, LT&#x003b1; &#x002dc;LT&#x003b2;, or LT&#x003b2;R 7 days post infection with 10e6 P. berghei ANKA parasitized red blood cells. Video 3 : PbA-infected TNF ko mouse. Compared to 2D views, 3D MRA allows a better observation of the vascular blood flow perturbations in wild-type and TNF-KO mice. Before 3D reconstruction, two dimensional angiograms (2D-MRA) were produced by Maximum Intensity Projections (MIP) as described in the <xref ref-type="sec" rid="s4">Methods</xref> section. Movies were created by rotating the 2D-MRA views at different angles (using steps of 20 degrees). Image analysis and processing (including 3D MRA movies) were performed with the public domain software ImageJ (NIH, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij</ext-link>).</p><p>(1.92 MB AVI)</p></caption><media xlink:href="pone.0002608.s003.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0002608.s004"><label>Video S4</label><caption><p>3D MRA Video 4 : PbA-infected LT&#x003b1;&#x003b2; ko mouse. Three-dimensional (3D) Magnetic Resonance Angiography (MRA) movies of non-infected wild-type C57BL/6, and wild-type or mice deficient for TNF, LT&#x003b1;LT&#x003b2;, or LT&#x003b2;R 7 days post infection with 10e6 P. berghei ANKA parasitized red blood cells. Video 4 : PbA-infected LT&#x003b1;&#x003b2; ko mouse. Compared to 2D views, 3D MRA allows a better observation of the vascular blood flow perturbations in wild-type and TNF-KO mice. Before 3D reconstruction, two dimensional angiograms (2D-MRA) were produced by Maximum Intensity Projections (MIP) as described in the <xref ref-type="sec" rid="s4">Methods</xref> section. Movies were created by rotating the 2D-MRA views at different angles (using steps of 20 degrees). Image analysis and processing (including 3D MRA movies) were performed with the public domain software ImageJ (NIH, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij</ext-link>).</p><p>(1.74 MB AVI)</p></caption><media xlink:href="pone.0002608.s004.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0002608.s005"><label>Video S5</label><caption><p>3D MRA Video 5 : PbA-infected LT&#x003b2;R ko mouse. Three-dimensional (3D) Magnetic Resonance Angiography (MRA) movies of non-infected wild-type C57BL/6, and wild-type or mice deficient for TNF, LT&#x003b1;LT&#x003b2;, or LT&#x003b2;R 7 days post infection with 10e6 P. berghei ANKA parasitized red blood cells. Video 4 : PbA-infected LT&#x003b2;R ko mouse. Compared to 2D views, 3D MRA allows a better observation of the vascular blood flow perturbations in wild-type and TNF-KO mice. Before 3D reconstruction, two dimensional angiograms (2D-MRA) were produced by Maximum Intensity Projections (MIP) as described in the <xref ref-type="sec" rid="s4">Methods</xref> section. Movies were created by rotating the 2D-MRA views at different angles (using steps of 20 degrees). Image analysis and processing (including 3D MRA movies) were performed with the public domain software ImageJ (NIH, <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij</ext-link>).</p><p>(1.71 MB AVI)</p></caption><media xlink:href="pone.0002608.s005.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors are grateful to Dr. Analbery Monteiro for thorough analysis of the MRI data.</p></ack><ref-list><title>References</title><ref id="pone.0002608-Miller1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>LH</given-names></name><name><surname>Good</surname><given-names>MF</given-names></name><name><surname>Milon</surname><given-names>G</given-names></name></person-group><year>1994</year><article-title>Malaria pathogenesis.</article-title><source>Science</source><volume>264</volume><fpage>1878</fpage><lpage>1883</lpage><pub-id pub-id-type="pmid">8009217</pub-id></citation></ref><ref id="pone.0002608-Idro1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Idro</surname><given-names>R</given-names></name><name><surname>Jenkins</surname><given-names>NE</given-names></name><name><surname>Newton</surname><given-names>CR</given-names></name></person-group><year>2005</year><article-title>Pathogenesis, clinical features, and neurological outcome of cerebral malaria.</article-title><source>Lancet Neurol</source><volume>4</volume><fpage>827</fpage><lpage>840</lpage><pub-id pub-id-type="pmid">16297841</pub-id></citation></ref><ref id="pone.0002608-Hunt1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>NH</given-names></name><name><surname>Grau</surname><given-names>GE</given-names></name></person-group><year>2003</year><article-title>Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria.</article-title><source>Trends Immunol</source><volume>24</volume><fpage>491</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">12967673</pub-id></citation></ref><ref id="pone.0002608-Schofield1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schofield</surname><given-names>L</given-names></name><name><surname>Grau</surname><given-names>GE</given-names></name></person-group><year>2005</year><article-title>Immunological processes in malaria pathogenesis.</article-title><source>Nat Rev Immunol</source><volume>5</volume><fpage>722</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">16138104</pub-id></citation></ref><ref id="pone.0002608-Grau1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grau</surname><given-names>GE</given-names></name><name><surname>Taylor</surname><given-names>TE</given-names></name><name><surname>Molyneux</surname><given-names>ME</given-names></name><name><surname>Wirima</surname><given-names>JJ</given-names></name><name><surname>Vassalli</surname><given-names>P</given-names></name><etal/></person-group><year>1989</year><article-title>Tumor necrosis factor and disease severity in children with falciparum malaria.</article-title><source>N Engl J Med</source><volume>320</volume><fpage>1586</fpage><lpage>1591</lpage><pub-id pub-id-type="pmid">2657427</pub-id></citation></ref><ref id="pone.0002608-Kern1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kern</surname><given-names>P</given-names></name><name><surname>Hemmer</surname><given-names>CJ</given-names></name><name><surname>Van Damme</surname><given-names>J</given-names></name><name><surname>Gruss</surname><given-names>HJ</given-names></name><name><surname>Dietrich</surname><given-names>M</given-names></name></person-group><year>1989</year><article-title>Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.</article-title><source>Am J Med</source><volume>87</volume><fpage>139</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">2667356</pub-id></citation></ref><ref id="pone.0002608-Kwiatkowski1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwiatkowski</surname><given-names>D</given-names></name><name><surname>Hill</surname><given-names>AV</given-names></name><name><surname>Sambou</surname><given-names>I</given-names></name><name><surname>Twumasi</surname><given-names>P</given-names></name><name><surname>Castracane</surname><given-names>J</given-names></name><etal/></person-group><year>1990</year><article-title>TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.</article-title><source>Lancet</source><volume>336</volume><fpage>1201</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">1978068</pub-id></citation></ref><ref id="pone.0002608-Grau2"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grau</surname><given-names>GE</given-names></name><name><surname>Fajardo</surname><given-names>LF</given-names></name><name><surname>Piguet</surname><given-names>PF</given-names></name><name><surname>Allet</surname><given-names>B</given-names></name><name><surname>Lambert</surname><given-names>PH</given-names></name><etal/></person-group><year>1987</year><article-title>Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.</article-title><source>Science</source><volume>237</volume><fpage>1210</fpage><lpage>1212</lpage><pub-id pub-id-type="pmid">3306918</pub-id></citation></ref><ref id="pone.0002608-Rudin1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rudin</surname><given-names>W</given-names></name><name><surname>Eugster</surname><given-names>HP</given-names></name><name><surname>Bordmann</surname><given-names>G</given-names></name><name><surname>Bonato</surname><given-names>J</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><etal/></person-group><year>1997</year><article-title>Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response.</article-title><source>Am J Pathol</source><volume>150</volume><fpage>257</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">9006341</pub-id></citation></ref><ref id="pone.0002608-Engwerda1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engwerda</surname><given-names>CR</given-names></name><name><surname>Mynott</surname><given-names>TL</given-names></name><name><surname>Sawhney</surname><given-names>S</given-names></name><name><surname>De Souza</surname><given-names>JB</given-names></name><name><surname>Bickle</surname><given-names>QD</given-names></name><etal/></person-group><year>2002</year><article-title>Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria.</article-title><source>J Exp Med</source><volume>195</volume><fpage>1371</fpage><lpage>1377</lpage><pub-id pub-id-type="pmid">12021316</pub-id></citation></ref><ref id="pone.0002608-Gommerman1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gommerman</surname><given-names>JL</given-names></name><name><surname>Browning</surname><given-names>JL</given-names></name></person-group><year>2003</year><article-title>Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.</article-title><source>Nat Rev Immunol</source><volume>3</volume><fpage>642</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">12974479</pub-id></citation></ref><ref id="pone.0002608-Fu1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>YX</given-names></name><name><surname>Chaplin</surname><given-names>DD</given-names></name></person-group><year>1999</year><article-title>Development and maturation of secondary lymphoid tissues.</article-title><source>Annu Rev Immunol</source><volume>17</volume><fpage>399</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">10358764</pub-id></citation></ref><ref id="pone.0002608-Ware1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>CF</given-names></name></person-group><year>2005</year><article-title>Network communications: lymphotoxins, LIGHT, and TNF.</article-title><source>Annu Rev Immunol</source><volume>23</volume><fpage>787</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">15771586</pub-id></citation></ref><ref id="pone.0002608-Hehlgans1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hehlgans</surname><given-names>T</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group><year>2005</year><article-title>The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.</article-title><source>Immunology</source><volume>115</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">15819693</pub-id></citation></ref><ref id="pone.0002608-Flynn1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Goldstein</surname><given-names>MM</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Triebold</surname><given-names>KJ</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><etal/></person-group><year>1995</year><article-title>Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.</article-title><source>Immunity</source><volume>2</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">7540941</pub-id></citation></ref><ref id="pone.0002608-Stoelcker1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoelcker</surname><given-names>B</given-names></name><name><surname>Hehlgans</surname><given-names>T</given-names></name><name><surname>Weigl</surname><given-names>K</given-names></name><name><surname>Bluethmann</surname><given-names>H</given-names></name><name><surname>Grau</surname><given-names>GE</given-names></name><etal/></person-group><year>2002</year><article-title>Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria.</article-title><source>Infect Immun</source><volume>70</volume><fpage>5857</fpage><lpage>5859</lpage><pub-id pub-id-type="pmid">12228317</pub-id></citation></ref><ref id="pone.0002608-Futterer1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Futterer</surname><given-names>A</given-names></name><name><surname>Mink</surname><given-names>K</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group><year>1998</year><article-title>The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues.</article-title><source>Immunity</source><volume>9</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">9697836</pub-id></citation></ref><ref id="pone.0002608-Scheu1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheu</surname><given-names>S</given-names></name><name><surname>Alferink</surname><given-names>J</given-names></name><name><surname>Potzel</surname><given-names>T</given-names></name><name><surname>Barchet</surname><given-names>W</given-names></name><name><surname>Kalinke</surname><given-names>U</given-names></name><etal/></person-group><year>2002</year><article-title>Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.</article-title><source>J Exp Med</source><volume>195</volume><fpage>1613</fpage><lpage>1624</lpage><pub-id pub-id-type="pmid">12070288</pub-id></citation></ref><ref id="pone.0002608-Penet1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Penet</surname><given-names>MF</given-names></name><name><surname>Viola</surname><given-names>A</given-names></name><name><surname>Confort-Gouny</surname><given-names>S</given-names></name><name><surname>Le Fur</surname><given-names>Y</given-names></name><name><surname>Duhamel</surname><given-names>G</given-names></name><etal/></person-group><year>2005</year><article-title>Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema.</article-title><source>J Neurosci</source><volume>25</volume><fpage>7352</fpage><lpage>7358</lpage><pub-id pub-id-type="pmid">16093385</pub-id></citation></ref><ref id="pone.0002608-Belnoue1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belnoue</surname><given-names>E</given-names></name><name><surname>Kayibanda</surname><given-names>M</given-names></name><name><surname>Vigario</surname><given-names>AM</given-names></name><name><surname>Deschemin</surname><given-names>JC</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><etal/></person-group><year>2002</year><article-title>On the pathogenic role of brain-sequestered alphabeta CD8&#x0002b; T cells in experimental cerebral malaria.</article-title><source>J Immunol</source><volume>169</volume><fpage>6369</fpage><lpage>6375</lpage><pub-id pub-id-type="pmid">12444144</pub-id></citation></ref><ref id="pone.0002608-Nitcheu1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nitcheu</surname><given-names>JBO</given-names></name><name><surname>Combadiere</surname><given-names>C</given-names></name><name><surname>Tefit</surname><given-names>M</given-names></name><name><surname>Seilhean</surname><given-names>D</given-names></name><name><surname>Mazier</surname><given-names>D</given-names></name><etal/></person-group><year>2003</year><article-title>Perforin-dependent brain-infiltrating cytotoxic CD8&#x0002b; T lymphocytes mediate experimental cerebral malaria pathogenesis.</article-title><source>Journal of Immunology</source><volume>170</volume><fpage>22221</fpage><lpage>22228</lpage></citation></ref><ref id="pone.0002608-Voza1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voza</surname><given-names>TVA</given-names></name><name><surname>Belnoue</surname><given-names>E</given-names></name><name><surname>Gr&#x000fc;ner</surname><given-names>AC</given-names></name><name><surname>Deschemin</surname><given-names>JC</given-names></name><name><surname>Kayibanda</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp.</article-title><source>Infect Immun</source><volume>73</volume><fpage>4777</fpage><lpage>4786</lpage><pub-id pub-id-type="pmid">16040990</pub-id></citation></ref><ref id="pone.0002608-Grau3"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grau</surname><given-names>GEPP</given-names></name><name><surname>Gretener</surname><given-names>D</given-names></name><name><surname>Vesin</surname><given-names>C</given-names></name><name><surname>Lambert</surname><given-names>PH</given-names></name></person-group><year>1988</year><article-title>Immunopathology of thrombocytopenia in experimental malaria.</article-title><source>Immunology</source><volume>65</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">3065215</pub-id></citation></ref><ref id="pone.0002608-Muller1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Eugster</surname><given-names>HP</given-names></name><name><surname>Le Hir</surname><given-names>M</given-names></name><name><surname>Shakhov</surname><given-names>A</given-names></name><name><surname>Di Padova</surname><given-names>F</given-names></name><etal/></person-group><year>1996</year><article-title>Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation.</article-title><source>Mol Med</source><volume>2</volume><fpage>247</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">8726467</pub-id></citation></ref><ref id="pone.0002608-Ryffel1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryffel</surname><given-names>B</given-names></name><name><surname>Di Padova</surname><given-names>F</given-names></name><name><surname>Schreier</surname><given-names>MH</given-names></name><name><surname>Le Hir</surname><given-names>M</given-names></name><name><surname>Eugster</surname><given-names>HP</given-names></name><etal/></person-group><year>1997</year><article-title>Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice.</article-title><source>J Immunol</source><volume>158</volume><fpage>2126</fpage><lpage>2133</lpage><pub-id pub-id-type="pmid">9036957</pub-id></citation></ref><ref id="pone.0002608-Basak1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>SKH</given-names></name><name><surname>Kearns</surname><given-names>JD</given-names></name><name><surname>Tergaonkar</surname><given-names>V</given-names></name><name><surname>O'Dea</surname><given-names>E</given-names></name><name><surname>Werner</surname><given-names>SL</given-names></name><etal/></person-group><year>2007</year><article-title>A fourth IkappaB protein within the NF-kappaB signaling module.</article-title><source>Cell</source><volume>128</volume><fpage>369</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">17254973</pub-id></citation></ref><ref id="pone.0002608-Katakai1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katakai</surname><given-names>THT</given-names></name><name><surname>Sugai</surname><given-names>M</given-names></name><name><surname>Gonda</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes.</article-title><source>Journal of Experimental Medecine</source><volume>200</volume><fpage>783</fpage><lpage>795</lpage></citation></ref><ref id="pone.0002608-vonZurMuhlen1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Zur Muhlen</surname><given-names>C</given-names></name><name><surname>Sibson</surname><given-names>NR</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name><name><surname>Campbell</surname><given-names>SJ</given-names></name><name><surname>Wilainam</surname><given-names>P</given-names></name><etal/></person-group><year>2008</year><article-title>A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI.</article-title><source>J Clin Invest</source><volume>118</volume><fpage>1198</fpage><lpage>1207</lpage><pub-id pub-id-type="pmid">18274670</pub-id></citation></ref><ref id="pone.0002608-Wunderlich1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wunderlich</surname><given-names>F</given-names></name><name><surname>Dkhil</surname><given-names>MA</given-names></name><name><surname>Mehnert</surname><given-names>LI</given-names></name><name><surname>Braun</surname><given-names>JV</given-names></name><name><surname>El-Khadragy</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Testosterone responsiveness of spleen and liver in female lymphotoxin beta receptor-deficient mice resistant to blood-stage malaria.</article-title><source>Microbes Infect</source><volume>7</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">15788153</pub-id></citation></ref><ref id="pone.0002608-Hall1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>NCJ</given-names></name></person-group><year>2005</year><article-title>Comparative genomics of malaria parasites.</article-title><source>Curr Opin Genet Dev</source><volume>15</volume><fpage>609</fpage><lpage>613</lpage><pub-id pub-id-type="pmid">16182520</pub-id></citation></ref><ref id="pone.0002608-Stevenson1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>MM</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name></person-group><year>2004</year><article-title>Innate immunity to malaria.</article-title><source>Nat Rev Immunol</source><volume>4</volume><fpage>169</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">15039754</pub-id></citation></ref><ref id="pone.0002608-Pichyangkul1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pichyangkul</surname><given-names>SGM</given-names></name><name><surname>Miller</surname><given-names>RS</given-names></name><name><surname>Lyon</surname><given-names>JA</given-names></name><name><surname>Angov</surname><given-names>E</given-names></name><name><surname>Tongtawe</surname><given-names>P</given-names></name><etal/></person-group><year>2004</year><article-title>Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.</article-title><source>Vaccine</source><volume>22</volume><fpage>3831</fpage><lpage>3840</lpage><pub-id pub-id-type="pmid">15364429</pub-id></citation></ref><ref id="pone.0002608-Coban1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coban</surname><given-names>C</given-names></name><name><surname>Ishii</surname><given-names>KJ</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Hemmi</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin.</article-title><source>J Exp Med</source><volume>201</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">15630134</pub-id></citation></ref><ref id="pone.0002608-Amani1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amani</surname><given-names>V</given-names></name><name><surname>Vigario</surname><given-names>AM</given-names></name><name><surname>Belnoue</surname><given-names>E</given-names></name><name><surname>Marussig</surname><given-names>M</given-names></name><name><surname>Fonseca</surname><given-names>L</given-names></name><etal/></person-group><year>2000</year><article-title>Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection.</article-title><source>Eur J Immunol</source><volume>30</volume><fpage>1646</fpage><lpage>1655</lpage><pub-id pub-id-type="pmid">10898501</pub-id></citation></ref><ref id="pone.0002608-Baratin1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baratin</surname><given-names>M</given-names></name><name><surname>Roetynck</surname><given-names>S</given-names></name><name><surname>Lepolard</surname><given-names>C</given-names></name><name><surname>Falk</surname><given-names>C</given-names></name><name><surname>Sawadogo</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>14747</fpage><lpage>14752</lpage><pub-id pub-id-type="pmid">16203971</pub-id></citation></ref><ref id="pone.0002608-Togbe1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Togbe</surname><given-names>DSL</given-names></name><name><surname>Grau</surname><given-names>GE</given-names></name><name><surname>Schnyder</surname><given-names>B</given-names></name><name><surname>Boissay</surname><given-names>V</given-names></name><name><surname>Charron</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Murine Cerebral Malaria development is independent of Toll-Like signaling.</article-title><source>Am J Pathol</source><volume>170</volume><fpage>1640</fpage><lpage>1648</lpage><pub-id pub-id-type="pmid">17456769</pub-id></citation></ref><ref id="pone.0002608-Renia1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Renia</surname><given-names>L</given-names></name><name><surname>Potter</surname><given-names>SM</given-names></name><name><surname>Mauduit</surname><given-names>M</given-names></name><name><surname>Rosa</surname><given-names>DS</given-names></name><name><surname>Kayibanda</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Pathogenic T cells in cerebral malaria.</article-title><source>Int J Parasitol</source><volume>36</volume><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">16600241</pub-id></citation></ref><ref id="pone.0002608-Chang1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>WL</given-names></name><name><surname>Jones</surname><given-names>SP</given-names></name><name><surname>Lefer</surname><given-names>DJ</given-names></name><name><surname>Welbourne</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><etal/></person-group><year>2001</year><article-title>CD8(&#x0002b;)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice.</article-title><source>Infect Immun</source><volume>69</volume><fpage>7341</fpage><lpage>7348</lpage><pub-id pub-id-type="pmid">11705906</pub-id></citation></ref><ref id="pone.0002608-Flori1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flori</surname><given-names>L</given-names></name><name><surname>Delahaye</surname><given-names>NF</given-names></name><name><surname>Iraqi</surname><given-names>FA</given-names></name><name><surname>Hernandez-Valladares</surname><given-names>M</given-names></name><name><surname>Fumoux</surname><given-names>F</given-names></name><etal/></person-group><year>2005</year><article-title>TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso.</article-title><source>Genes Immun</source><volume>6</volume><fpage>472</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">15931230</pub-id></citation></ref><ref id="pone.0002608-McGuire1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGuire</surname><given-names>WHA</given-names></name><name><surname>Allsopp</surname><given-names>CE</given-names></name><name><surname>Greenwood</surname><given-names>BM</given-names></name><name><surname>Kwiatkowski</surname><given-names>D</given-names></name></person-group><year>1994</year><article-title>Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.</article-title><source>Nature</source><volume>371</volume><fpage>508</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">7935762</pub-id></citation></ref><ref id="pone.0002608-Wattavidanage1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wattavidanage</surname><given-names>JCR</given-names></name><name><surname>Perera</surname><given-names>KL</given-names></name><name><surname>Munasingha</surname><given-names>A</given-names></name><name><surname>Bandara</surname><given-names>S</given-names></name><name><surname>McGuinness</surname><given-names>D</given-names></name><etal/></person-group><year>1999</year><article-title>TNFalpha&#x0002a;2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans.</article-title><source>Clin Exp Immunol</source><volume>115</volume><fpage>350</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">9933464</pub-id></citation></ref><ref id="pone.0002608-Aidoo1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aidoo</surname><given-names>MMP</given-names></name><name><surname>Kolczak</surname><given-names>MS</given-names></name><name><surname>Terlouw</surname><given-names>DJ</given-names></name><name><surname>ter Kuile</surname><given-names>FO</given-names></name><name><surname>Nahlen</surname><given-names>B</given-names></name><etal/></person-group><year>2001</year><article-title>Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX.</article-title><source>Genet Epidemiol</source><volume>21</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">11668577</pub-id></citation></ref><ref id="pone.0002608-Gimenez1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gimenez</surname><given-names>FBdLS</given-names></name><name><surname>Fernandez</surname><given-names>C</given-names></name><name><surname>Pino</surname><given-names>P</given-names></name><name><surname>Mazier</surname><given-names>D</given-names></name></person-group><year>2003</year><article-title>Tumor necrosis factor alpha in the pathogenesis of cerebral malaria.</article-title><source>Cell Mol Life Sci</source><volume>60</volume><fpage>1623</fpage><lpage>1635</lpage><pub-id pub-id-type="pmid">14504653</pub-id></citation></ref><ref id="pone.0002608-Marino1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname><given-names>MW</given-names></name><name><surname>Dunn</surname><given-names>A</given-names></name><name><surname>Grail</surname><given-names>D</given-names></name><name><surname>Inglese</surname><given-names>M</given-names></name><name><surname>Noguchi</surname><given-names>Y</given-names></name><etal/></person-group><year>1997</year><article-title>Characterization of tumor necrosis factor-deficient mice.</article-title><source>Proc Natl Acad Sci U S A</source><volume>94</volume><fpage>8093</fpage><lpage>8098</lpage><pub-id pub-id-type="pmid">9223320</pub-id></citation></ref><ref id="pone.0002608-DeTogni1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Togni</surname><given-names>P</given-names></name><name><surname>Goellner</surname><given-names>J</given-names></name><name><surname>Ruddle</surname><given-names>NH</given-names></name><name><surname>Streeter</surname><given-names>PR</given-names></name><name><surname>Fick</surname><given-names>A</given-names></name><etal/></person-group><year>1994</year><article-title>Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.</article-title><source>Science</source><volume>264</volume><fpage>703</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">8171322</pub-id></citation></ref><ref id="pone.0002608-Alimzhanov1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alimzhanov</surname><given-names>MB</given-names></name><name><surname>Kuprash</surname><given-names>DV</given-names></name><name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></name><name><surname>Luz</surname><given-names>A</given-names></name><name><surname>Turetskaya</surname><given-names>RL</given-names></name><etal/></person-group><year>1997</year><article-title>Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.</article-title><source>Proc Natl Acad Sci U S A</source><volume>94</volume><fpage>9302</fpage><lpage>9307</lpage><pub-id pub-id-type="pmid">9256477</pub-id></citation></ref><ref id="pone.0002608-Kuprash1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuprash</surname><given-names>DV</given-names></name><name><surname>Alimzhanov</surname><given-names>MB</given-names></name><name><surname>Tumanov</surname><given-names>AV</given-names></name><name><surname>Anderson</surname><given-names>AO</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><etal/></person-group><year>1999</year><article-title>TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.</article-title><source>J Immunol</source><volume>163</volume><fpage>6575</fpage><lpage>6580</lpage><pub-id pub-id-type="pmid">10586051</pub-id></citation></ref><ref id="pone.0002608-Rothe1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothe</surname><given-names>J</given-names></name><name><surname>Lesslauer</surname><given-names>W</given-names></name><name><surname>Lotscher</surname><given-names>H</given-names></name><name><surname>Lang</surname><given-names>Y</given-names></name><name><surname>Koebel</surname><given-names>P</given-names></name><etal/></person-group><year>1993</year><article-title>Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.</article-title><source>Nature</source><volume>364</volume><fpage>798</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">8395024</pub-id></citation></ref><ref id="pone.0002608-Erickson1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>SL</given-names></name><name><surname>de Sauvage</surname><given-names>FJ</given-names></name><name><surname>Kikly</surname><given-names>K</given-names></name><name><surname>Carver-Moore</surname><given-names>K</given-names></name><name><surname>Pitts-Meek</surname><given-names>S</given-names></name><etal/></person-group><year>1994</year><article-title>Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice.</article-title><source>Nature</source><volume>372</volume><fpage>560</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">7990930</pub-id></citation></ref><ref id="pone.0002608-FrankeFayard1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franke-Fayard</surname><given-names>B</given-names></name><name><surname>Janse</surname><given-names>CJ</given-names></name><name><surname>Cunha-Rodrigues</surname><given-names>M</given-names></name><name><surname>Ramesar</surname><given-names>J</given-names></name><name><surname>Buscher</surname><given-names>P</given-names></name><etal/></person-group><year>2005</year><article-title>Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>11468</fpage><lpage>11473</lpage><pub-id pub-id-type="pmid">16051702</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Work supported by CNRS, the interdisciplinary program MIE from the French Research Minister, and European FP6 MPCM project.</p></fn></fn-group></back></article> 